← Back to Search
Behavioural Intervention
MCII + MOVE! Program for Weight Management (WOOP VA Trial)
New York, NY
N/A
Waitlist Available
Led By Melanie R. Jay, MD MS
Research Sponsored by VA Office of Research and Development
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
BMI of 30kg/m2 (with or without obesity-associated comorbidities) OR a BMI of 25kg/m2 with obesity-associated condition (heart diseases, hyperlipidemia, hypertension, cancer, diabetes, stroke, or osteoarthritis)
Age 18-70
Must not have
a documented current history of active psychosis or other cognitive issues via ICD-10 codes
Diagnosed with Parkinson's disease and/or severe arthritis
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 and 12 months
Awards & highlights
No Placebo-Only Group
Summary
This trial will test whether adding a mental contrasting with implementation intentions (MCII) strategy to the VA's MOVE! weight management program will help Veterans who are enrolled in the program to lose weight.
See full description
Who is the study for?
This trial is for Veterans aged 18-70 with obesity or related conditions, willing to join the MOVE! program and able to attend evaluations in Manhattan VA. They must have had a primary care visit within the past year, desire weight loss, and be reachable by phone. Excluded are those seeing dietitians frequently, recently hospitalized, involved in other weight studies or taking certain weight loss drugs.Check my eligibility
What is being tested?
The study tests whether adding Mental Contrasting with Implementation Intentions (MCII) strategy via 'WOOP' technique to telephone-delivered MOVE! enhances weight management compared to just using telephone-delivered MOVE!. Participants will receive guidance on diet and exercise during baseline visits and follow-up check-ins.See study design
What are the potential side effects?
Since this trial involves lifestyle interventions like dietary changes and physical activity rather than medication, side effects may include typical exercise-related issues such as muscle soreness or fatigue. Psychological discomfort could also occur from changing long-standing habits.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
My BMI is 30 or higher, or it's 25 or higher with a related health condition.
show original
Select...
I am between 18 and 70 years old.
show original
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
I have been diagnosed with active psychosis or cognitive issues.
show original
Select...
I have been diagnosed with Parkinson's disease or severe arthritis.
show original
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 6 and 12 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 and 12 months
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Secondary study objectives
Change in Self Reported Physical Activity
Healthy Eating Index change
MOVE! Attendance change
+3 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Mental Contrasting with Implementation Intentions (WOOP) plus MOVE! /TeleMOVE!Experimental Treatment4 Interventions
At the baseline visit, a lay educator will teach the WOOP technique in-person using protocols adapted from our prior work. After, to support WOOP practice, the lay educator will schedule and provide 3 follow-up telephone check-ins with the Veteran. This arm will also receive telephone-delivered MOVE!/TeleMOVE!
Group II: Telephone Delivered MOVE!/TeleMOVE!Active Control2 Interventions
During the baseline visit, Veterans randomized to the control arm will receive only the standard information about MOVE!/TeleMOVE!, diet, and physical activity delivered by the same lay educators. They will not learn the WOOP technique as detailed below. Data collection during study visits will be at the same timepoints in both arms.
Find a Location
Closest Location:VA NY Harbor Healthcare System, New York, NY· New York, NY
Who is running the clinical trial?
VA Office of Research and DevelopmentLead Sponsor
1,687 Previous Clinical Trials
3,758,341 Total Patients Enrolled
43 Trials studying Obesity
15,956 Patients Enrolled for Obesity
New York UniversityOTHER
247 Previous Clinical Trials
228,323 Total Patients Enrolled
7 Trials studying Obesity
3,712 Patients Enrolled for Obesity
Melanie R. Jay, MD MSPrincipal InvestigatorVA NY Harbor Healthcare System, New York, NY
2 Previous Clinical Trials
346 Total Patients Enrolled
2 Trials studying Obesity
346 Patients Enrolled for Obesity
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- At least one prior PCP visit in the past year, access to a telephone, the ability to travel to Manhattan VA for in-person evaluations at baseline, 6 and 12 months.I want to lose weight and my desire is at least a 4 out of 10.I have been diagnosed with active psychosis or cognitive issues.My BMI is 30 or higher, or it's 25 or higher with a related health condition.My BMI is 30 or higher, or it's 25 or higher with a related health condition.I am willing to enroll in the MOVE! program.I have been diagnosed with Parkinson's disease or severe arthritis.I can travel to Manhattan VA for evaluations when needed.I am between 18 and 70 years old.I want to lose weight and my desire is at least a 5 out of 10.I am taking a prescribed weight loss medication.I am willing to enroll in the MOVE! program.I am between 18 and 70 years old.
Research Study Groups:
This trial has the following groups:- Group 1: Telephone Delivered MOVE!/TeleMOVE!
- Group 2: Mental Contrasting with Implementation Intentions (WOOP) plus MOVE! /TeleMOVE!
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.